Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Griffin

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Andrology|June 25, 1998
Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drugG M Waites, C Wang, P D Griffin
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
ImmunocontraceptivesV C Stevens, P D Griffin, W R Jones
Andrologia|August 9, 2007
Effects of levonorgestrel butanoate alone and in combination with testosterone buciclate on spermatogenesis in the bonnet monkeyR S Sharma, P C Pal, P D Griffin, et al.
Journal of Reproductive Immunology|March 1, 1987
Monoclonal antibodies to human trophoblast and sperm antigens: report of two WHO-sponsored workshops, June 30, 1986--Toronto, CanadaD J Anderson, P M Johnson, N J Alexander, et al.
International Journal of Andrology|April 13, 2000
Evaluation of the ability of levonorgestrel butanoate alone, or in combination with testosterone buciclate, to suppress spermatogenesis in the bonnet monkey (Macaca radiata)M Rajalakshmi, P C Pal, D A Jeyaraj, et al.
Lancet (London, England)|June 11, 1988
Phase I clinical trial of a World Health Organisation birth control vaccineW R Jones, J Bradley, S J Judd, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Andrology|June 25, 1998
Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drugG M Waites, C Wang, P D Griffin
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
ImmunocontraceptivesV C Stevens, P D Griffin, W R Jones
Andrologia|August 9, 2007
Effects of levonorgestrel butanoate alone and in combination with testosterone buciclate on spermatogenesis in the bonnet monkeyR S Sharma, P C Pal, P D Griffin, et al.
Journal of Reproductive Immunology|March 1, 1987
Monoclonal antibodies to human trophoblast and sperm antigens: report of two WHO-sponsored workshops, June 30, 1986--Toronto, CanadaD J Anderson, P M Johnson, N J Alexander, et al.
International Journal of Andrology|April 13, 2000
Evaluation of the ability of levonorgestrel butanoate alone, or in combination with testosterone buciclate, to suppress spermatogenesis in the bonnet monkey (Macaca radiata)M Rajalakshmi, P C Pal, D A Jeyaraj, et al.
Lancet (London, England)|June 11, 1988
Phase I clinical trial of a World Health Organisation birth control vaccineW R Jones, J Bradley, S J Judd, et al.
Pageof 2